Defining molecular risk in ALK + NSCLC
https://doi.org/10.18632/oncotarget.26886 Petros Christopoulos, Jan Budczies, Martina Kirchner, Steffen Dietz, Holger Sültmann, Michael Thomas, Albrecht Stenzinger
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
May 03, 2019
|
| In: |
OncoTarget
Year: 2019, Jahrgang: 10, Heft: 33, Pages: 3093-3103 |
| ISSN: | 1949-2553 |
| DOI: | 10.18632/oncotarget.26886 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.18632/oncotarget.26886 Verlag, lizenzpflichtig, Volltext: https://www.oncotarget.com/article/26886/text/ |
| Verfasserangaben: | Petros Christopoulos, Jan Budczies, Martina Kirchner, Steffen Dietz, Holger Sültmann, Michael Thomas, Albrecht Stenzinger |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1694664457 | ||
| 003 | DE-627 | ||
| 005 | 20220818042203.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200416s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.18632/oncotarget.26886 |2 doi | |
| 035 | |a (DE-627)1694664457 | ||
| 035 | |a (DE-599)KXP1694664457 | ||
| 035 | |a (OCoLC)1341315279 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Christopoulos, Petros |d 1977- |e VerfasserIn |0 (DE-588)138659702 |0 (DE-627)604886756 |0 (DE-576)308488067 |4 aut | |
| 245 | 1 | 0 | |a Defining molecular risk in ALK + NSCLC |c Petros Christopoulos, Jan Budczies, Martina Kirchner, Steffen Dietz, Holger Sültmann, Michael Thomas, Albrecht Stenzinger |
| 264 | 1 | |c May 03, 2019 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 16.04.2020 | ||
| 520 | |a https://doi.org/10.18632/oncotarget.26886 Petros Christopoulos, Jan Budczies, Martina Kirchner, Steffen Dietz, Holger Sültmann, Michael Thomas, Albrecht Stenzinger | ||
| 700 | 1 | |a Budczies, Jan |d 1970- |e VerfasserIn |0 (DE-588)124086403 |0 (DE-627)706532724 |0 (DE-576)186167679 |4 aut | |
| 700 | 1 | |a Kirchner, Martina |d 1973- |e VerfasserIn |0 (DE-588)1017178976 |0 (DE-627)676266363 |0 (DE-576)353239747 |4 aut | |
| 700 | 1 | |a Dietz, Steffen |d 1988- |e VerfasserIn |0 (DE-588)1148996575 |0 (DE-627)1009298062 |0 (DE-576)496511556 |4 aut | |
| 700 | 1 | |a Sültmann, Holger |d 1962- |e VerfasserIn |0 (DE-588)172777291 |0 (DE-627)697708144 |0 (DE-576)133633926 |4 aut | |
| 700 | 1 | |a Thomas, Michael |e VerfasserIn |0 (DE-588)1054438781 |0 (DE-627)79152213X |0 (DE-576)41027089X |4 aut | |
| 700 | 1 | |a Stenzinger, Albrecht |e VerfasserIn |0 (DE-588)139606106 |0 (DE-627)703395238 |0 (DE-576)312432755 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t OncoTarget |d [Erscheinungsort nicht ermittelbar] : Impact Journals LLC, 2010 |g 10(2019), 33, Seite 3093-3103 |h Online-Ressource |w (DE-627)63035975X |w (DE-600)2560162-3 |w (DE-576)325343764 |x 1949-2553 |7 nnas |a Defining molecular risk in ALK + NSCLC |
| 773 | 1 | 8 | |g volume:10 |g year:2019 |g number:33 |g pages:3093-3103 |g extent:11 |a Defining molecular risk in ALK + NSCLC |
| 856 | 4 | 0 | |u https://doi.org/10.18632/oncotarget.26886 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.oncotarget.com/article/26886/text/ |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200416 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 139606106 |a Stenzinger, Albrecht |m 139606106:Stenzinger, Albrecht |d 910000 |d 912000 |e 910000PS139606106 |e 912000PS139606106 |k 0/910000/ |k 1/910000/912000/ |p 7 |y j | ||
| 998 | |g 1054438781 |a Thomas, Michael |m 1054438781:Thomas, Michael |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PT1054438781 |e 950000PT1054438781 |e 950900PT1054438781 |e 50000PT1054438781 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 6 | ||
| 998 | |g 172777291 |a Sültmann, Holger |m 172777291:Sültmann, Holger |d 50000 |e 50000PS172777291 |k 0/50000/ |p 5 | ||
| 998 | |g 1148996575 |a Dietz, Steffen |m 1148996575:Dietz, Steffen |p 4 | ||
| 998 | |g 1017178976 |a Kirchner, Martina |m 1017178976:Kirchner, Martina |d 50000 |e 50000PK1017178976 |k 0/50000/ |p 3 | ||
| 998 | |g 124086403 |a Budczies, Jan |m 124086403:Budczies, Jan |d 910000 |d 912000 |e 910000PB124086403 |e 912000PB124086403 |k 0/910000/ |k 1/910000/912000/ |p 2 | ||
| 998 | |g 138659702 |a Christopoulos, Petros |m 138659702:Christopoulos, Petros |d 910000 |d 950000 |d 950900 |e 910000PC138659702 |e 950000PC138659702 |e 950900PC138659702 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 1 |x j | ||
| 999 | |a KXP-PPN1694664457 |e 3624023489 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Petros Christopoulos, Jan Budczies, Martina Kirchner, Steffen Dietz, Holger Sültmann, Michael Thomas, Albrecht Stenzinger"]},"id":{"eki":["1694664457"],"doi":["10.18632/oncotarget.26886"]},"recId":"1694664457","physDesc":[{"extent":"11 S."}],"person":[{"display":"Christopoulos, Petros","family":"Christopoulos","given":"Petros","role":"aut"},{"family":"Budczies","given":"Jan","role":"aut","display":"Budczies, Jan"},{"display":"Kirchner, Martina","given":"Martina","role":"aut","family":"Kirchner"},{"given":"Steffen","role":"aut","family":"Dietz","display":"Dietz, Steffen"},{"family":"Sültmann","given":"Holger","role":"aut","display":"Sültmann, Holger"},{"family":"Thomas","given":"Michael","role":"aut","display":"Thomas, Michael"},{"given":"Albrecht","role":"aut","family":"Stenzinger","display":"Stenzinger, Albrecht"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"recId":"63035975X","disp":"Defining molecular risk in ALK + NSCLCOncoTarget","origin":[{"dateIssuedKey":"2010","publisherPlace":"[Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"2010-","publisher":"Impact Journals LLC"}],"pubHistory":["1.2010,Mai -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 16.08.2018"],"id":{"issn":["1949-2553"],"eki":["63035975X"],"zdb":["2560162-3"]},"part":{"volume":"10","year":"2019","text":"10(2019), 33, Seite 3093-3103","extent":"11","issue":"33","pages":"3093-3103"},"title":[{"title":"OncoTarget","title_sort":"OncoTarget","subtitle":"open access impact journal"}]}],"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"May 03, 2019"}],"title":[{"title_sort":"Defining molecular risk in ALK + NSCLC","title":"Defining molecular risk in ALK + NSCLC"}],"note":["Gesehen am 16.04.2020"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"]} | ||
| SRT | |a CHRISTOPOUDEFININGMO0320 | ||